Fintel reports that on January 8, 2025, TD Cowen downgraded their outlook for Science Applications International ...

Fintel reports that on January 8, 2025, TD Cowen downgraded their outlook for Kimberly-Clark (NYSE:KMB) from Buy to Hold.

The cost of prescription drugs is set to climb in 2025 and beyond, according to TD Cowen’s 30th Annual Drug Pricing survey.

In a report released today, Brendan Smith from TD Cowen maintained a Buy rating on Halozyme (HALO – Research Report), with a price target of ...

TD Cowen analyst Jason Gabelman maintained a Buy rating on Exxon Mobil (XOM – Research Report) today. The company’s shares closed today at ...

TD Cowen has recently reiterated Marathon Petroleum Corp (MPC) stock to Buy rating, as announced on December 10, 2024, according to Finviz. Earlier, on November 6, 2024, TD Cowen had reiterated the ...

“Two-thousand-twenty-four was a tough year for staples stocks, and 2025 is shaping up to be even tougher,” says TD Cowen ...

Shares of American Airlines surged Monday after brokerages Jefferies and TD Cowen upgraded and raised their price targets on ...

When the BIOSECURE Act hit a setback and missed the chance of becoming law in 2024, the deceleration of the draft legislation ...

American Airlines' stock is poised for a strong 2025 as the carrier emerges from a challenging year, according to brokerages ...

The chain wants to improve customer experience by making its stores more welcoming and speeding up service. But will the ...

The upgrades come as American Airlines has seen a substantial improvement in its domestic market, with competitors making ...